Takeda
VPRIV
Manufacturer:
Takeda
Name:
VPRIV
HCPCS Code Descriptor:
Injection, velaglucerase alfa, 100 units
Category:
J Code
HCPCS:
J3385
NDC(s):
54092-0701-04
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
VPRIV is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J3385 is aligned to the drug VPRIV.